dc.contributor.author | Gerken, Guido | |
dc.contributor.author | Janssen, Harry L. | |
dc.contributor.author | Simon, Krzysztof | |
dc.contributor.author | Boucher, Charles A. | |
dc.contributor.author | Hansen, Bettina E. | |
dc.contributor.author | Senturk, Hakan | |
dc.contributor.author | Sonneveld, Milan J. | |
dc.contributor.author | Rijckborst, Vincent | |
dc.contributor.author | Zeuzem, Stefan | |
dc.contributor.author | AKARCA, ULUS SALİH | |
dc.date.accessioned | 2021-03-05T07:43:41Z | |
dc.date.available | 2021-03-05T07:43:41Z | |
dc.identifier.citation | Sonneveld M. J. , Rijckborst V., Senturk H., Zeuzem S., AKARCA U. S. , Simon K., Gerken G., Boucher C. A. , Hansen B. E. , Janssen H. L. , "HBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE", 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 29 Ekim - 02 Kasım 2010, cilt.52 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_954c68ff-44c3-4e2e-b4cf-db0bec1b67f0 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/100525 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.title | HBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE | |
dc.type | Bildiri | |
dc.contributor.department | Erasmus University Rotterdam , , | |
dc.identifier.volume | 52 | |
dc.contributor.firstauthorID | 137474 | |